View in EDS HTML Full Text PDF Full Text

Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.

Saved in:
Bibliographic Details
Title: Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
Authors: Saif MW; Northwell Health Cancer Institute, Lake Success, NY, USA., Rosen L; University of California, Los Angeles, CA, USA., Rudek MA; Johns Hopkins University, Baltimore, MD, USA., Sun W; University of Kansas, Kansas City, KS, USA., Shepard DR; Cleveland Clinic, Cleveland, OH, USA., Becerra C; Texas Oncology, Baylor University Medical Center, Dallas, TX, USA., Yamashita F; Taiho Oncology, Inc, Princeton, NJ, USA., Bebeau P; Taiho Oncology, Inc, Princeton, NJ, USA., Winkler R; Taiho Oncology, Inc, Princeton, NJ, USA.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Jun; Vol. 85 (6), pp. 1239-1246. Date of Electronic Publication: 2019 Mar 28.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30628113
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saif+MW%22">Saif MW</searchLink>; Northwell Health Cancer Institute, Lake Success, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rosen+L%22">Rosen L</searchLink>; University of California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rudek+MA%22">Rudek MA</searchLink>; Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sun+W%22">Sun W</searchLink>; University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Shepard+DR%22">Shepard DR</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Becerra+C%22">Becerra C</searchLink>; Texas Oncology, Baylor University Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yamashita+F%22">Yamashita F</searchLink>; Taiho Oncology, Inc, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bebeau+P%22">Bebeau P</searchLink>; Taiho Oncology, Inc, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Winkler+R%22">Winkler R</searchLink>; Taiho Oncology, Inc, Princeton, NJ, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2019 Jun; Vol. 85 (6), pp. 1239-1246. <i>Date of Electronic Publication: </i>2019 Mar 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30628113
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bcp.13856
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1239
    Titles:
      – TitleFull: Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saif MW
      – PersonEntity:
          Name:
            NameFull: Rosen L
      – PersonEntity:
          Name:
            NameFull: Rudek MA
      – PersonEntity:
          Name:
            NameFull: Sun W
      – PersonEntity:
          Name:
            NameFull: Shepard DR
      – PersonEntity:
          Name:
            NameFull: Becerra C
      – PersonEntity:
          Name:
            NameFull: Yamashita F
      – PersonEntity:
          Name:
            NameFull: Bebeau P
      – PersonEntity:
          Name:
            NameFull: Winkler R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2019 Jun
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2125
          Numbering:
            – Type: volume
              Value: 85
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: British journal of clinical pharmacology
              Type: main
ResultId 1